Developments in Strategy and HTA
Originally broadcast: Tuesday 8th September 2020 at 12:30 – 14:00 BST
Duration: 90 minutes. Available to watch on demand
Learning objectives:
Get the latest insights and information for accelerating patient access
Understand the value and importance of patient engagement throughout the HTA process
Discover the benefits of using patient registries in HTAs
Compare the appraisal process of medical devices compared with drugs and pinpoint what can be learnt from each process
Who would benefit from registering to attend this webinar:
This webinar should be attended by representatives from UK, European and global pharmaceutical, biotech, life science and MedTech industries, as well as patient organisations and patient groups.
The job functions that will benefit most include:
• Heads of Market Access
• Managing Directors
• Country Managers
• Chief Executives
• Health Economists
• Medical Directors
• Commercial Directors
• Policy Officers/Executives
• Marketing Directors
• Policy Advisors
Speakers
Josie Godfrey, Trustee, Metabolic Support UK
Josie Godfrey has over 18 years’ experience in health policy and stakeholder engagement. She set up the NICE Highly Specialised Technologies programme and its predecessor the Advisory Group for National Specialised Services (AGNSS). Josie is a Trustee of Metabolic Support UK, an umbrella organisation that provides support and advocacy for patients and families affected by inherited metabolic disorders.
David Gillen, Vice President international Medical Affairs, Vertex
David is an experienced VP within the biotechnology industry. He is skilled in Oncology, Haematology, and Pharmacovigilance. In addition, be being the Vice President International Medical Affairs at Vertex, he is also their international GMDA lead.
Jasdeep Hayre, Associate Director, NICE
Health Economist Jasdeep has been with NICE for 9 years in a range of technical with responsibility across commissioning and management of contractors and leading on overall economic outputs for safe staffing guidelines.
Copyright © 2020. MAP BioPharma Limited. All rights reserved.
MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom
+44 (0) 1480 832360
MAP BioPharma Limited is a registered company in England and Wales. Company Registration Number 08209281
VAT Group Registration Number GB 292 8576 52